Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | CEO, Medicare Advantage | October 07, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date October 07, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,792,690 |
Reported balance
After 2026-10-07 transaction · row 1
1 source rowRow 1 · 2026-10-07 · Sale · Disposed 2,006 · Balance 2,792,690 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 7, 2026 22:20 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,006 | $4.63 | $9,287.78 |
DisclosureSEC source: 0001839066-26-000054 · wk-form4_1791411631.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,792,690 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 05, 2026 Filed Oct 5, 2026 23:00 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 8,750 | $4.42 | $38,675.00 |
DisclosureSEC source: 0001839066-26-000052 · wk-form4_1791241251.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,794,696 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the "RSUs") on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 20:22 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 1,921 | $4.56 | $8,759.76 |
DisclosureSEC source: 0001839066-26-000047 · wk-form4_1789762962.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,803,446 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 23:48 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 9,273 | $4.78 | $44,324.94 |
DisclosureSEC source: 0001839066-26-000045 · wk-form4_1789516081.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,805,367 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the final 6.25% of restricted stock units (the "RSUs") on September 15, 2026. The RSUs were originally granted to the Reporting Person on September 16, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 17, 2026 Filed Jul 17, 2026 21:26 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,839 | $4.53 | $21,920.67 |
DisclosureSEC source: 0001839066-26-000039 · wk-form4_1784323597.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,814,640 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 13,119 | $4.67 | $61,265.73 |
DisclosureSEC source: 0001801170-26-000176 · wk-form4_1784235002.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,819,479 F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 08, 2026 Filed Jul 9, 2026 20:45 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,384 | $4.68 | $11,157.12 |
DisclosureSEC source: 0001839066-26-000033 · wk-form4_1783629938.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,832,598 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Read SEC document |
| July 06, 2026 Filed Jul 6, 2026 21:57 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 6,229 | $5.26 | $32,764.54 |
DisclosureSEC source: 0001839066-26-000031 · wk-form4_1783375051.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,834,982 F1 · kind: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 10:42 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,360 | $4.78 | $11,280.80 |
DisclosureSEC source: 0001839066-26-000024 · wk-form4_1781779319.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,841,211 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks: Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 12:14 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 6,350 | $4.61 | $29,273.50 |
DisclosureSEC source: 0001839066-26-000022 · wk-form4_1781612073.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,843,571 F1 · kind: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 11, 2026 Filed Jun 11, 2026 21:28 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 7,289 | $4.91 | $35,788.99 |
DisclosureSEC source: 0001839066-26-000017 · wk-form4_1781213277.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,849,921 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks: Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,712 | $2.04 | $25,932.48 |
DisclosureSEC source: 0001839066-26-000015 · wk-form4_1776370186.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,857,210 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 20:28 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,197 | $1.72 | $10,658.84 |
DisclosureSEC source: 0001839066-26-000014 · wk-form4_1775593688.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,869,922 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:34 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 159,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001839066-26-000012 · wk-form4_1775248480.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,876,119 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030. Read SEC document |
| March 18, 2026 Filed Mar 18, 2026 22:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 5,833 | $1.91 | $11,141.03 |
DisclosureSEC source: 0001839066-26-000009 · wk-form4_1773871875.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,716,735 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.96, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks: Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,187 | $1.98 | $12,250.26 |
DisclosureSEC source: 0001839066-26-000007 · wk-form4_1773779577.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,722,568 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,945 | $1.98 | $17,711.10 |
DisclosureSEC source: 0001839066-26-000007 · wk-form4_1773779577.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,728,755 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. Read SEC document |
| January 20, 2026 Filed Jan 20, 2026 22:38 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,597 | $2.58 | $11,860.26 |
DisclosureSEC source: 0001801170-26-000024 · wk-form4_1768948713.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,737,700 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.47 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 22:38 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 14,732 | $2.81 | $41,396.92 |
DisclosureSEC source: 0001801170-26-000024 · wk-form4_1768948713.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,742,297 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2026 Filed Jan 7, 2026 22:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,102 | $2.53 | $5,318.06 |
DisclosureSEC source: 0001839066-26-000004 · wk-form4_1767823793.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,757,029 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.61, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2026 Filed Jan 5, 2026 21:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,109 | $2.41 | $19,542.69 |
DisclosureSEC source: 0001839066-26-000002 · wk-form4_1767647372.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,759,131 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 00:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,913 | $2.61 | $12,822.93 |
DisclosureSEC source: 0001839066-25-000029 · wk-form4_1766102986.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,767,240 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.58 to $2.64, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 00:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $2.70 | $23,465.70 |
DisclosureSEC source: 0001839066-25-000027 · wk-form4_1765933145.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772,153 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 00:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $2.70 | $33,930.90 |
DisclosureSEC source: 0001839066-25-000027 · wk-form4_1765933145.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,780,844 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 21:46 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 30,385 | $3.58 | $108,778.30 |
DisclosureSEC source: 0001839066-25-000025 · wk-form4_1762379210.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,793,411 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.49 to $3.67, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 22:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 29,513 | $3.53 | $104,180.89 |
DisclosureSEC source: 0001839066-25-000022 · wk-form4_1762294579.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,823,796 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 22:16 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 101,917 | $3.53 | $359,767.01 |
DisclosureSEC source: 0001839066-25-000022 · wk-form4_1762294579.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,853,309 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 20:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 16,514 | $2.69 | $44,422.66 |
DisclosureSEC source: 0001839066-25-000019 · wk-form4_1761077350.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,955,226 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.72, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:44 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 71,432 | $2.80 | $200,009.60 |
DisclosureSEC source: 0001839066-25-000017 · wk-form4_1760733859.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,971,740 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 07, 2025 Filed Oct 7, 2025 20:37 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,012 | $2.65 | $5,331.80 |
DisclosureSEC source: 0001801170-25-000240 · wk-form4_1759869459.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,043,172 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. These shares were sold at a price of $2.65. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:37 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,706 | $2.59 | $22,548.54 |
DisclosureSEC source: 0001801170-25-000240 · wk-form4_1759869459.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,045,184 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 20:13 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 4,914 | $3.09 | $15,184.26 |
DisclosureSEC source: 0001839066-25-000010 · wk-form4_1758312781.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,053,890 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.13, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 21:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $3.14 | $27,289.74 |
DisclosureSEC source: 0001801170-25-000229 · wk-form4_1758056852.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,058,804 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 14, 2025 Filed Sep 16, 2025 21:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $3.06 | $38,455.02 |
DisclosureSEC source: 0001801170-25-000229 · wk-form4_1758056852.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,067,495 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 6,823 | $2.89 | $19,718.47 |
DisclosureSEC source: 0001801170-25-000198 · wk-form4_1754513958.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,261,485 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $2.93, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 29,513 | $2.89 | $85,292.57 |
DisclosureSEC source: 0001801170-25-000188 · wk-form4_1754343063.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,268,308 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 07, 2025 Filed Jul 8, 2025 21:15 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 2,012 | $2.85 | $5,734.20 |
DisclosureSEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 3 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,297,821 F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.88, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 03, 2025 Filed Jul 8, 2025 21:15 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,706 | $2.56 | $22,287.36 |
DisclosureSEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,299,833 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| July 03, 2025 Filed Jul 8, 2025 21:15 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 19,789 | $2.58 | $51,055.62 |
DisclosureSEC source: 0001801170-25-000168 · wk-form4_1752009297.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,308,539 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:47 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,596 | $2.79 | $238,812.84 |
DisclosureSEC source: 0001801170-25-000165 · wk-form4_1751489245.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,328,328 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:47 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 217,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000165 · wk-form4_1751489245.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,413,924 F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. The final one-third of the number of earned restricted stock units vested and were settled on June 30, 2025. Read SEC document |
| June 30, 2025 Filed Sep 16, 2025 21:00 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 85,596 | $2.79 | $238,812.84 |
DisclosureSEC source: 0001839066-25-000008 · wk-form4a_1758056455.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,887,905 F1 · shares: This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below. F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025. F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 21:26 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 20,450 | $2.86 | $58,487.00 |
DisclosureSEC source: 0001801170-25-000162 · wk-form4_1750281969.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,196,401 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.92, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:36 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $2.89 | $25,116.99 |
DisclosureSEC source: 0001801170-25-000158 · wk-form4_1750192547.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,216,851 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| June 14, 2025 Filed Jun 17, 2025 20:36 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $2.89 | $36,318.63 |
DisclosureSEC source: 0001801170-25-000158 · wk-form4_1750192547.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,225,542 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 25,659 | $3.40 | $87,240.60 |
DisclosureSEC source: 0001801170-25-000113 · wk-form4_1746217990.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,238,109 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 20:40 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,366 | $3.51 | $22,344.66 |
DisclosureSEC source: 0001801170-25-000079 · wk-form4_1744058416.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,263,768 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:53 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 6,354 | $3.66 | $23,255.64 |
DisclosureSEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270,134 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:53 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 9,188 | $3.66 | $33,628.08 |
DisclosureSEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,276,488 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 21,578 | $4.39 | $94,727.42 |
DisclosureSEC source: 0001801170-25-000038 · wk-form4_1738703923.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,285,676 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.